David W. Andersen
Papers
1
Total Citations
77
H-Index
1
About
David W. Andersen is a leading figure in forensic toxicology and clinical bioanalysis, specializing in the detection and quantification of drugs and their metabolites in biological matrices. His most cited work, published in 2013, introduced a groundbreaking method for the simultaneous analysis of 31 illicit and medicinal drugs and metabolites in whole blood using fully automated solid-phase extraction coupled with ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS). This highly cited study (77 citations) revolutionized high-throughput toxicological screening by significantly reducing sample preparation time and enhancing sensitivity and specificity, making it a cornerstone reference for forensic laboratories worldwide. Andersen’s contributions have advanced the reliability of postmortem and clinical drug testing, directly impacting public health and legal investigations. His work exemplifies the integration of automation and cutting-edge mass spectrometry to address complex analytical challenges, earning him recognition as a key innovator in the field. For students and researchers, Andersen’s research underscores the critical role of method development in ensuring accurate and efficient drug monitoring in real-world scenarios.
Research Focus
Key Achievements
Top Papers
- 1